NP575325.RAqOEHKqyJPzvJCnP L-1Z5npjRNGi-g6pCyk 8Q-x4 k
type: Nanopublication
has assertion: NP575325.RAqOEHKqyJPzvJCnP L-1Z5npjRNGi-g6pCyk 8Q-x4 k130 assertion
has provenance: NP575325.RAqOEHKqyJPzvJCnP L-1Z5npjRNGi-g6pCyk 8Q-x4 k130 provenance
has publication info: NP575325.RAqOEHKqyJPzvJCnP L-1Z5npjRNGi-g6pCyk 8Q-x4 k130 publicationInfo
created: 2014-10-02T12:37:47+02:00
rights: http://opendatacommons.org/licenses/odbl/1.0/
rights holder: IBIGroup
subject: SIO_000983
used data: disgenetrdf
authored by: http://orcid.org/0000-0001-5999-6269
authored by: http://orcid.org/0000-0002-7534-7661
authored by: 0000-0002-9383-528X
authored by: http://orcid.org/0000-0003-0169-8159
authored by: http://orcid.org/0000-0003-1244-7654
created by: http://orcid.org/0000-0003-0169-8159
version: v2.1.0.0

NP575325.RAqOEHKqyJPzvJCnP L-1Z5npjRNGi-g6pCyk 8Q-x4 k130 assertion
type: Assertion
description: [We have previously shown that the p38 MAPK inhibitor SB203580 (SB) significantly induced Cyp1a1 gene expression at the mRNA and activity levels, whereas it dramatically inhibited the induction of Cyp1a1 by TCDD in murine hepatoma Hepa 1c1c7 cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine.
evidence: DisGeNET evidence - LITERATURE
SIO_000772: http://identifiers.org/pubmed/21732638
was generated by: ECO_0000203

befree-20140225
imported on: 2014-02-25

DisGeNET evidence - LITERATURE
type: ECO_0000212
comment: Gene-disease associations inferred from text-mining the literature.

disgenetrdf
version: v2.1.0